Patton just celebrated what he calls his “LVAD-versary.” In June 2023, a left ventricular assist device (LVAD) was implanted in his heart, circulating his blood while he waits for a transplant.

An uninterruptable wireless power supply is developed for a left ventricular assist device (LVAD), which is an implanted, electrically driven centrifugal pump used to treat advanced heart failure ...

This study deals with the thermal analysis of a transcutaneous energy transfer (TET) system, based on the magnetic resonant coupling technology, to wirelessly power a left ventricular assist device ...

How the CorWave LVAD works The device uses a revolutionary oscillating membrane, rather than a rotating propeller, to pump blood around the body.

CorWave today announced the world's first human implantation of its left ventricular assist device (LVAD) in Australia.

The Impella device (Impella, Abiomed, Danvers, MA) is a percutaneous transvalvular microaxial flow pump that is currently used for (1) cardiogenic shock, (2) left ventricular unloading (combination of ...

The organization of health care systems is increasingly recognized as a key component of optimal stroke care. This guideline recommends development of regional systems that provide initial ...

FDA and Mesoblast agreed on trial design and key CMC items for Revascor BLA filing. Mesoblast plans to seek accelerated approval for Revascor in LVAD patients by year-end. The market’s back, and ...

Laws vary sometimes even from city to city when it comes to keeping the power on for life support customers who make late payments.